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Background: Infinium HumanMethylation 450 BeadChip Arrays by Illumina (Illumina HM450K) are among the
most popular CpG microarray platforms widely used in biological and medical research. Several recent studies
highlighted the potentially confounding impact of the genomic variation on the results of methylation studies
performed using Illumina’s Infinium methylation probes. However, the complexity of SNPs impact on the
methylation level measurements (β values) has not been comprehensively described.
Results: In our comparative study of European and Asian populations performed using Illumina HM450K, we
found that the majority of Infinium probes, which differentiated two examined groups, had SNPs in their target
sequence. Characteristic tri-modal or bi-modal patterns of β values distribution among individual samples were
observed for CpGs with SNPs in the first and second position, respectively. To better understand how SNPs affect
methylation readouts, we investigated their impact in the context of SNP position and type, and of the Illumina
probe type (Infinium I or II).
Conclusions: Our study clearly demonstrates that SNP variation existing in the genome, if not accounted for,
may lead to false interpretation of the methylation signal differences suggested by some of the Illumina Infinium
probes. In addition, it provides important practical clues for discriminating between differences due to the methylation
status and to the genomic polymorphisms, based on the inspection of methylation readouts in individual samples. This
approach is of special importance when Illumina Infinium assay is used for any comparative population studies,
whether related to cancer, disease, ethnicity where SNP frequencies differentiate the studied groups.
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Infinium probesBackground
Human DNA methylation studies have become an im-
portant part of many biological and medical research areas
[1, 2]. A number of methods for analyzing genome-wide
methylation profiles have been developed and validated
[3–9]. Illumina Infinium HumanMethylation 450 Bead-
Chip Array (HM450K array) is one of the most popular
CpG microarray platforms used to quantify genome-wide* Correspondence: zietkiee@man.poznan.pl
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The number of methylation studies performed with
the use of Illumina HM450K array have been published
in various research fields, including studies on cancer,
disease, ethnicity, aging, and gender, and it still grows
exponentially [1, 10–15]. Great popularity of the Illu-
mina platform stems from its ability to test methylation
at the genome-wide scale (over 480 000 predefined CpG
sites) combined with the relatively low cost of the assay.article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Daca-Roszak et al. BMC Genomics  (2015) 16:1003 Page 2 of 13Recently, some technical limitations of the Infinium
platform have been recognized, leading to the recom-
mendation for a more careful interpretation of DNA
methylation results from the HM450K array [12, 16–19].
The limitations reflect suboptimal probe design, e.g.
probes hybridizing to multiple map addresses, probes
located within repetitive sequences, or probes targeting
genomic sequence containing SNPs. All these factors
affect determination of β or M values (measures of the
methylation level); if not accounted for, they may lead to
false interpretation of Illumina microarray results.
Recently, the list of Illumina HM450K probes likely to
provide a “noisy” signal (with the recommendation for
being discarded from methylation studies) was published
[19]. Among a total of 485,512 Illumina probes, 70,118
were affected by SNPs or INDELS at interrogated CpG
sites, including 12,746 Infinium I and 57,372 Infinium II
probes. While very helpful, the study by Naeem et al.
[19] does not characterize the impact of specific categories
of potentially confounding factors on the interpret-
ation of Illumina HM450K results in the context of
population studies.
The presence of SNPs at the CpG loci targeted by
Illumina Infinium probes is one of the most important
confounding variables, especially when methylation levels
are compared among individuals from genetically non-
homogeneous populations. Our interest in comparative
population genetics prompted us to characterize the the-
oretical and practical impact of SNPs on the methylation
readouts and on the interpretation of population data.
Using exemplary results obtained with the use of Infinium
probes in male B-lymphocyte lines from two human
continental populations: Caucasian (European) and East
Asian (Chinese), we illustrate how SNPs at the interro-
gated CpG loci affect the resulting methylation calls. Our
study provides important practical clues for using
HM450K array in comparative population studies.
Results
Selection of differentiating probes
Methylation microarray analysis of 36 European and
East Asian cell lines revealed a total of 34,024 sites
differentiating two populations) at the significance level
p < 0.05. Of those, 120 CpG sites were characterized by
q < 0.05, and arbitrarily set |Mav_diff| > 0.3. These sites
included 33 CpGs targeted by Infinium probes type I
and 87 by probes type II, and were used to demonstrate
the impact of genomic SNPs on the interpretation of
methylation readout from HM450K array. A subset of
96 CpG sites (23 and 73 probes type I and II, respect-
ively), representing the highest inter-population differ-
ences (|Mav_diff| > 1; q < 0.05) was provisionally termed
“population-differentiating” (pop-diff ) CpGs. The cut-off
at |Mav_diff| > 1 roughly corresponded to that of anabsolute difference in β value > 0.2 [20], representing
approximately a difference in DNA methylation levels
of 20 %.
There was no global methylation difference between
interrogated populations (p = 0.67).
Genomic location of differentiating probes
We examined the 96 pop-diff probes (Mdiff > 0.1; q < 0.05)
for the presence of neighboring probes, located 500 bp
up- or downstream from the investigated CpG. 53 of the
96 pop-diff probes had no other probes in the vicinity; the
remaining 43 had from one to six neighbors. Altogether,
there were 106 additional probes, 33 of which (31 %)
differentiated two populations (Mdiff 0.2–0.49); however,
the majority of these were not included in the list of
96 pop-diff because they did not fulfill the require-
ment of q < 0.05.
Among 96 pop-diff probes, only two pairs (with no
SNP in the interrogated CpG) mapped to the same
chromosome region each. cg04287289 and cg26513180
were 8 bp apart on chromosome 16 (Mdiff values 1.96
and 1.62 respectively); cg26367031 and cg00862290 were
226 bp apart on chromosome 3 (Mdiff values 2.77 and
2.78 respectively). The remaining pop-diff probes, when
localized on the same chromosome, were separated from
one another by much larger distances (for 68 probes the
distance was > 126 kb, for 5: between 1.8 and 74.8 kb).
Probes targeting CpG sites with genomic SNPs
Among 96 pop-diff CpGs representing the highest inter-
population differences between Europeans and Asians
(|Mav_diff| > 1; q < 0.05), we frequently observed a high
proportion of probes with a tri-modal or bi-modal distribu-
tion of the individual β values. This distribution resembled
clustering expected for heterozygous and homozygous
forms of SNP genotypes, also reported in earlier
studies [16, 19].
Indeed, in silico analysis of the sequences in the UCSC
Genome Browser database revealed that the majority
(66/96, i.e. 69 %) of the pop-diff CpG sites contained
common genomic SNPs (the minor allele frequency
MAF > 0.01) with the allele frequencies strongly differen-
tiating two analysed populations (MAF_diff > 0.1). Fst
values calculated for each of these SNPs were in the
range of 0.51–0.013.). The average genetic distance
between European and East Asian populations based on
these 66 SNPs was 0.26 (+ − 0.11), which is significantly
more than the average Fst of 0.10–0.15 or less, reported
for inter-continental comparisons of human populations
(e.g. [21] and references therein).
In contrast, among 24 weakly differentiating CpG sites
(Mav_diff < 1; q < 0.05), only 25 % had a SNP in the inter-
rogated CpG. These observations suggested that the
large proportion of population differences detected by
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epigenetic differences. None of these CpGs corre-
sponded to the 65 control Illumina probes (rs) that assay
highly-polymorphic single nucleotide polymorphisms
(SNPs) and are intentionally included in the HM450K
array to allow sample quality control and indicate the
degree of technical variance between samples. All the
probes targeting pop-diff CpGs with SNPs in the interro-
gated sequence belonged to the class flagged to be
discarded from methylation analyses by Naeem et al. [19].
The proportion of pop-diff CpGs containing frequent
SNPs was higher for type II (54/73; 74 %) than for type I
Infinium probes (12/23; 52 %). When the position of a
SNP within the interrogated CpG was considered, seven
type I pop-diff probes had SNP in the first, and five—in
the second CpG position; for type II pop-diff probes, 46
had SNP in the first, and eight—in the second CpG
position. No significant differences between the number
of probes with SNPs in the first and second CpG pos-
ition were observed in a set of 24 weakly differentiating
probes. This comparison clearly indicated that the
population-differentiating capacity was mainly restricted
to type II probes, with a frequent SNP in the first
position of the interrogated CpG. This effect was seen
both when a SNP in CpG was the only confounding
factor, and when it was combined with other factors
listed by Naeem et al. [19], like under-a-probe SNPs,
probes localizing to the genomic repeats, or mapping at
different genomic locations etc. (Fig. 1).
The excess of Infinium type II among the pop-diff
probes with SNPs can be related to the fact that most of
the CpGs interrogated by these probes are located in the
genomic sea, outside of the presumably more evolution-
ary conserved CpG islands and shores (regions of ~2 kbFig. 1 Occurrence of probes from the set of 120 characterized by FDR q <
(Mav_diff <1). Vertical axis — count of probes targeting CpG sites divided into
differentiating SNP in the first or second position of the interrogated CpG
the interrogated CpG combined with other confounding factors; Other — pr
CpG (SNPs in the probe sequence outside the interrogated CpG, indels, multi
potentially the only probes indicating true methylation level differencesadjacent to CpG islands, as defined by Illumina) interro-
gated by Infinium I probes.
The impact of SNPs in the interrogated CpG sites on the
pattern of β values distribution
In our study, the majority of pop-diff Infinium probes
targeting CpG sites with common SNPs, yielded charac-
teristic patterns of β values distribution among the
examined cell lines: tri-modal, bi-modal, and cloud-like.
In order to facilitate interpretation of such distributions,
we examined potential factors influencing these patters.
For individual probes, the pattern depended on: the SNP
position in the interrogated CpG site; the probe type
(Infinium I or II); and the methylation status of the wild
type CpG allele at the examined locus. It has to be
emphasized that in over 40 % of the pop-diff probes with
a SNP in the targeted dinucleotide, other potentially
confounding features were present; however, for most of
them the presence of a SNP in the interrogated CpG
appeared to exert the strongest effect upon methylation
readouts. For the sake of clarity, examples presented
below represent probes with SNPs in the interrogated
CpG sites and with no other confounding factors. The
examples are not intended to cover the whole range of
variability in β values distribution. Instead, they are
chosen to illustrate some of the mechanisms that
influence the readouts, and possibly to help in the
interpretation of some ambiguous results that may be
encountered when using Illumina Infinium probes.
Tri-modal distribution of β values
The most conspicuous and very frequent pattern
observed among pop-diff CpGs in our study, was that of
a tri-modal distribution of β values (see example in0.05. a. Pop-diff probes (Mav_diff >1). b. Weakly differentiating probes
categories listed along the horizontal axis: SNP_1CpG or SNP_2CpG —
as the only confounding factor; SNP_(1,2) CpG & other — SNP in
obes with the confounding factors other than SNP in the interrogated
-map, repeats, mixed etc.); Clean — probes with no confounding factor,
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SNP was present in the first position of the dinucleotide
interrogated by type II Infinium probes (see Fig. 2b).
Individuals with the TpG genotype had low, CpG/TpG
heterozygotes—intermediate, and CpG homozygote-
s—high β values. Therefore, the tri-modal distribution of
β values reflected distribution of the SNP genotype
frequencies in the examined populations.
While low β values observed for TpG alleles reflected
the genomic status of the polymorphic site rather than
the low level of methylation, high β values for CpG
homozygotes indicated that CpG alleles were strongly
methylated; if CpG alleles in polymorphic CpG sites
were not methylated, both alleles would be indistin-
guishable after conversion, resulting in uniformly low β
values due to the lack of the green (methylation-specific)
fluorescence signal from the probes.Fig. 2 Example of a tri-modal pattern of β values distribution. a. Upper panel:
(cg23556238) interrogating CpG site with a SNP (C>T) in the first position. Ver
Samples 1–18 – East Asian population, samples 18–36 –European population
cell lines with CpG (blue), TpG (yellow) and CpG/TpG (red) genotypes. The tri-
Box plot graph showing fluorescence readouts for the probe cg23556238. Th
a result of probe extension with differently labelled dideoxynucleotides: green
All lines with homozygous CpG genotypes display strong green and no red sig
display strong red and no green signal, mimicking unmethylated status; hetero
Each boxplot represents interquartile range of the signals from all the probes f
the third quartile, respectively, and the black line inside the box corresponds to
(>1.5 distance from the upper quartile). b. Sequence of the Infinium II probe (c
genotype, dideoxy-A will be incorporated giving red fluorescence signal falsely
degenerated sites complementary to under-a-probe CpGs (“YG” in the BCD seq
interrogated dinucleotide)A similar tri-modal distribution was also observed
when C in the first position of the interrogated CpG
sites was substituted by A or G. In most CpG sites with
a SNP in the first position, the concurrent presence of
another confounding factor, like SNPs, indels or repeats
under a probe, had only minor effect compared to the
influence of SNP in the interrogated site and did not dis-
turb the tri-modal distribution of β values (not shown).
Bi-modal distribution of β values
Another striking pattern, that of a bi-modal β distribu-
tion, was typically seen in CpGs with a G/A SNP at the
second position (Fig. 3a- upper panel), interrogated by
either type I or type II Infinium probes. In most cases,
CpG homozygotes had high β values suggesting strong
methylation of the interrogated dinucleotide. In CpA
alleles, we intuitively expected β values to be very low,Individual β values for 36 cell lines examined using the probe type II
tical axis — individual β values; horizontal axis — individual cell lines.
. High, low, and intermediate β values are observed, respectively, in the
modal distribution is that of beta values (along the Y axis). Lower panel:
e normalized signals (values indicated on the vertical axis) are detected as
and red, indicating methylated and unmethylated status, respectively.
nal, indicating methylated status; lines with homozygous TpG genotypes
zygotes have equal intensity of both red and green fluorescence signals.
or a given cell line. The bottom and top of the box represent the first and
the median. Black circles in the upper part of the graph are outlier values
g23556238), aligned with the genomic sequence. According to TpG
indicating unmethylated status. “RC” in the probe sequence represents
uence indicates no assumption of the concordant methylation with the
Fig. 3 Example of a bi-modal pattern of β values distribution. a. Upper panel: Individual β values for 36 cell lines examined using the type I probe
(cg16310958) interrogating CpG site with a SNP (G>A) in the second position. High β values are observed in cell lines with CpG (blue) and CpG/
TpA (red) genotypes, low—in lines with CpA (TpA in converted DNA; yellow) genotypes. Similar bi-modal distributions were also observed when
CpG sites with SNPs in the second position were interrogated by type II probes (not shown). Lower panel: Fluorescence readouts for the probe
cg16310958. Signals are detected as a result of the extension of probes M (green) and U (red). All lines with homozygous CpG genotypes
display strong green and no red signal, indicating methylated status. In heterozygotes the only readable signal is that from M probes. In lines with
homozygous CpA (TpA in converted DNA) genotypes, fluorescence signals from both M and U probes are very low. b. Sequences of the cg16310958
probes M and U, aligned with the genomic sequence with the G>A substitution in the second position of the interrogated dinucleotide
(TpA allele- bold and underlined). Additional CpG site under the probes (marked in red) appear to have the same methylation status as
the CpG allele in the interrogated site. Neither U nor M probe would hybridize efficiently to the TpG allele
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TpA dinucleotide (CpA allele, being no longer “methyl-
able”, is converted to TpA after bisulfite treatment).
Surprisingly, β values in CpA homozygotes were raised,
for some probes even up to the mid-level; at the same
time, β values in heterozygotes did not differ from those
obtained for CpG homozygotes. To explain this shift
towards high β values, observed in all genotypes
containing allele with a SNP in the second position of
the interrogated CpG site, we looked closer at the
possible factors, which could influence fluorescence
readouts and the calculation of β values.
Inefficient hybridization of the probes to the converted
TpA template resulted in the lack of probe extension,
and thus very low residual fluorescence signals, both sig-
nalMeth and signalUnmeth (see data in Fig. 3a lower
panel). This was true for both type I and type II Infinium
probes. In type II probes, the lack of both red and green
signals (indicating methylated and unmethylated status,respectively) resulted from the mismatch between the T
in the interrogated dinucleotide (TpA in the converted
DNA) and the probe’s sequence, always ending in C (see
Tables 1 and 2). For Infinium type I, both M and U probes
were doubly mismatched at their 3′ ends (Fig. 3b).
In CpG/CpA (CpG/TpA after conversion) heterozy-
gotes therefore, the only significant contribution to
the fluorescence readout was from the probes indicat-
ing methylation (green signal), and β values did not
differ from those obtained for methylated CpG homo-
zygotes (see Fig. 3a – upper panel-right part). In CpA
(TpA after conversion) homozygotes, with no contri-
bution from the methylated CpG allele, both fluores-
cent signalMeth and signalUnmeth were very low
compared to those in CpG homozygotes or in hetero-
zygotes (see Fig. 3a- lower panel). These low signals,
when entered in the equation β = signalMeth/(signal-
Meth + signalUnmeth), artificially inflated the respect-
ive β values.
Table 1 Predicted impact of SNPs in the interrogated CpG on methylation readout using Infinium I probes
*see also Fig. 4c.
Interrogated CpG sites are underlined and bolded. BCD — bisulfite converted DNA; NR — not relevant (no CpG in the genomic sequence); strikethrough — mismatch
between the probe and the interrogated locus; highlighted italics — incorporated fluorescently labeled ddNTPs; highlighted dots adjacent to the 3′-most position of the
probe — no probe extension; lower case “gc” and “ac” in the, respectively, M and U probe sequences should be complementary to CpGs and TpGs under a probe
(methylation status concordant with that of the interrogated dicnucleotide); “YG” in the BCD sequence indicates that the methylation status of the under-a-probe CpGs
cannot be predicted when the interrogated dinucleotide contains SNP
Table 2 Predicted impact of SNPs in CpG on methylation readout using Infinium II probes
BCD - bisulfite converted DNA; NR – not relevant (no CpG in the genomic sequence); strikethrough – mismatch between the probe and the interrogated locus;
italics – incorporated fluorescently labeled ddNTPs (C, G – green =methylation signal; A, T – red = unmethylation signal); dots adjacent to the 3′-most position
of the probe indicate no probe extension; “RC” in the probe sequence represents degenerated sites complementary to under-a-probe CpGs (“YG” in the BCD
sequence indicates no assumption of the concordant methylation with the interrogated dinucleotide)
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fluorescence signals
An artificial increase of β values (misleadingly suggesting
methylation status), as described above, affected both
type I and type II probes interrogating CpG site with a
G/A SNP in the second position. A similar effect was
observed when Infinium type I probes were used to in-
terrogate CpG sites with a C/T SNP in the first position.
Here, the mechanism of low fluorescence signals
reflected the nature of Infinium type I probes, which as-
sume concordant methylation of the neighbouring
CpGs. In the example illustrated in Fig. 4a, high β values
for CpG homozygotes indicated that under-a-probe
CpGs were methylated. The presence of a TpG allele in
the interrogated dinucleotide resulted in the mismatch
of both U and M probes ( Fig. 4b); inefficiently hybridiz-
ing probes failed to extend, and very low fluorescence
signals were observed (Fig. 4a; lower panel). In conse-
quence, β values in all TpG-containing genotypes wereFig. 4 Example of the effect of abnormally low fluorescence readouts. a. U
type I probe (cg10428733) interrogating CpG site with a SNP (C>T) in the f
cell lines with CpG (blue), TpG (yellow) and CpG/TpG (red) genotypes. Low
detected as a result of the extension of M (green) and U (red) probes. Al
no red signal, indicating methylated status. In lines with homozygous Tp
low (only one colour is visible, due to the overlapping red and green signals)
Sequences of the cg10428733 probes M and U, aligned with the genomic se
first position of the interrogated dinucleotide (bold and underlined). Three ad
same methylation status as the CpG allele in the interrogated site. Neither U n
due to the mismatch at the interrogated TpG, and the U probe in addition, d
to the 3′ end of the probe.artificially inflated, which resulted in a flattened pat-
tern, with all β values clustering in the upper range
(Fig. 4a- upper panel).A cloud-like distribution of β values
For a number of pop-diff probes, the impact of substitu-
tions in the interrogated CpGs was ambiguous, with no
clear correlation between the β values and the SNP ge-
notypes. A typical characteristics of these patterns was a
cloud-like pattern, with varying level of β values for CpG
homozygotes, which indicated non-uniform level of CpG
methylation. In these cases, β values for heterozygotes
were variable, and homozygotes for non-CpG alleles
usually had low β values (Fig. 5).
It has to be emphasized that similar cloud-like pat-
terns of individual β values distribution were also ob-
served when probes targeted “clean” CpGs (with no
SNPs or other confounding factors). In these cases,pper panel: Individual β values for 36 cell lines examined using the
irst position. Only high and intermediate β values are observed, in
er panel: Fluorescence readouts for the probe cg10428733. Signals are
l lines with homozygous CpG genotypes display strong green and
G genotypes fluorescence signals from both probes are extremely
. In heterozygotes the only readable signal comes from M probes. b.
quence (shown in opposed orientation) with the C>T substitution in the
ditional CpG sites under the probes (marked in red) appear to have the
or M probe would hybridize efficiently to the TpG allele: the M probe
ue to the mismatch with methylated under-a-probe CpGs, localized close
Fig. 5 Examples of an ambiguous impact of SNP on the distribution of β values. Upper panel: Individual β values for 36 cell lines examined using
the type II probe (cg14175932) interrogating CpG site with a SNP(C>T) at the first position. Low β values observed in most of the East Asian cell
lines are concordant with the predominant presence of TpG alleles (yellow) in this population. The dispersed, intermediate β values observed
in European population correspond to cell lines with CpG (blue) and CpG/TpG (red) genotypes; grey tags denote genotypes not confirmed
experimentally. The varying β values for heterozygotes and CpG homozygotes indicate partial methylation status of the CpG alleles. Lower panel:
Fluorescence readouts for the probe cg14175932 (Infinium II). Cell lines with homozygous TpG genotypes display strong red and no green signal,
mimicking unmethylated status; heterozygotes have nearly-equal, medium-range intensity of both red and green fluorescence signals; all lines
with homozygous CpG genotypes display similar green and red signal, indicating non-uniform methylation status
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cribed to real differences in the level of methylation be-
tween the studied groups (the need for further
validation notwithstanding). In the example presented
in Fig. 6, individual β values were very low in European
samples, while in Asians, they were distributed between
0 and 60 % of the full methylation status. This probe is
currently under validation by our research team, with
the use of pyrosequencing (to be published).Discussion
The predicted impact of SNPs on the methylation readout
The impact of SNPs on methylation readouts (β values)
in the Illumina HM450K array, while predicted, has not
been well characterized so far. Here we analyzed the the-
oretical, expected outcome in the context of different
SNPs and probes, and compared it to the observed
distribution of β values in the examined cell lines.
Among the factors that influence the impact of SNPs
on the β values, the polymorphism’s location and type
(in the interrogated dinucleotide or under a probe;
affecting the first or the second position of the CpG) are
the most obvious. Furthermore, because of the differ-
ences in the chemistry underlying signal detection when
using Infinium I and II probes, SNP’s effect strongly
depends on the type of Infinium probes (see Tables 1
and 2). Any SNP effect will be also influenced by thepresence/absence of other factors, like indels, probe’s
mapping to multiple locations, probes localized within
genomic repeats, inconsistency with Whole Genome
Bisulfite Sequencing (WGBS sequencing) (e.g. [19]).
Here, for the sake of clarity, we only focused on the ana-
lysis of probes with SNPs, with no other confounding
factors.SNPs under a probe
Among a variety of possible simple polymorphisms, the
C>T or T>C substitutions, if present outside CpG dinu-
cleotides, have no effect on the methylation readouts.
This is due to the bisulfite treatment, which converts all
Cs not involved in CpGs to Ts, such that the converted
sequence behaves as if it was non-polymorphic (classi-
fied as “bisulfite-OK” by [19]). Any other substitutions
located under a probe may affect the stability of probe’s
hybridization and thus its extension efficiency; the effect
of a mismatch would be stronger for SNPs located close
to the 3′ end of the probe. In addition, if under-a-probe
SNPs occur in CpG dinucleotides, their destabilizing
effect would be stronger for the type I probe pairs (M
and U, which assume concordant methylation status of
the adjacent CpGs) and less obvious for the degenerated
type II probes.
The effect of under-a-probe SNPs is not uniform and
cannot be easily predicted from the probe sequence and
Fig. 6 Example of β values distribution for one of the “clean” Infinium probes (with no SNP in the interrogated CpG site and no other confounding
effect). Upper panel: Individual β values for the type I probe (cgx* — the probe’s name is not disclosed — validation study in progress; manuscript in
preparation). Upper panel: Fluorescence readouts for the probe cgx. In the absence of SNPs, strong red and no green signal indicate unmethylated
status, while similar, medium-range intensity of green and red signals indicates a partial methylation status
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the literature: some authors had suggested that SNPs within
10 bp of the interrogated CpG can affect probes [16], while
others claimed that SNPs in the probe body may have little
effect on the recorded methylation state [19].
SNPs located in the interrogated CpGs
SNPs located in the interrogated CpGs have a potential
to affect the Illumina HM450K array readouts in a more
direct manner. Tables 1 and 2 summarize the predicted
effects of SNP polymorphisms in the first and second
position of the CpG site on the methylation readouts
when interrogated by type II and I probes, respectively.
Substitutions in the first position of the interrogated
CpG site
For type I probes, the genomic C>T substitution in the in-
terrogated CpG site renders it undistinguishable from the
bisulfite-converted unmethylated dinucleotide (TpG).
However, it has to be remembered that if the interrogated
CpG was methylated, the C>T substitution would change
the presumed concordance in the methylation status be-
tween the tested dinucleotide and under-a-probe CpGs.
This would lead to an inefficient attachment of not only
one but of both probes. The resulting low fluorescence
readouts from both probes, compared to relatively high
readouts from the same probes efficiently hybridizing with
CpG alleles, would affect β values and return false esti-
mates of the methylation level (see examples in the section
“Distribution of β values for probes with abnormally low
fluorescence signals”). The influence of the C>A or C>G
substitutions in the interrogated CpG sites is difficult topredict; these substitutions would affect hybridization of
the probe at its 3′ end, thus lowering the extension
efficiency of both M and U probes.
For type II probes, the genomic C>T in the interro-
gated CpG site also mimics the unmethylated status of
the examined dinucleotide in the bisulfite-converted
DNA, resulting in the red fluorescence signal (incorpor-
ation of a complementary A). The genomic C>A substi-
tution would give a similar signal (the red fluorescence
signals from the incorporation of A or T are not distin-
guishable); the genomic C>G, in turn, would mimic the
methylated status of the dinucleotide (the green fluores-
cence signals from the incorporation of C or G are also
not distinguishable). Unlike in type I probes, the readouts
of degenerated type II probes do not depend on the con-
cordance between the methylation status of the interro-
gated dinucleotide and adjacent CpG.
Substitutions in the second position of the interrogated
CpG site
Substitutions in the second position of the interrogated
CpG site (G>A, G>T or G>C) have a strong impact on
methylation measurements using Infinium probes. They
all act in a way similar to SNPs complementary to the
3′-most end of the probe, by affecting the hybridization
and thus strongly lowering or completely blocking the
efficiency of the probe’s extension. This results in very
low fluorescence readouts for any type of the Illumina
probes (type I—U and M, and type II), affecting the cal-
culation of β value and returning false estimates of the
methylation level (see below). It has to be emphasized
that any substitution in the second position of the CpG
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nucleotide in the bisulfite-converted DNA; e.g. genomic
CpA becomes TpA.
Summary estimates versus individual beta values and
normalized fluorescence redouts
In the routine analysis of the data from Illumina HM450
array, an average methylation level in each studied group
(βav or Mav) is calculated, and used to assess the popula-
tion/group difference of the methylation status for each
probe [13, 22]. This approach is straightforward if the
interrogated CpGs are not polymorphic at the level of a
genomic sequence. The examples presented above
explain some of the mechanisms, by which SNPs in the
interrogated dinucleotides may exert an impact on the
results of the comparative methylation studies using Illu-
mina Infinium probes. In a population with the high fre-
quency of a CpG allele, the βav value depends on its
methylation status. However, in a population with the
high frequency of a non-CpG allele, the βav value does
not reflect the real (un)methylation status. The analysis of
the distribution of individual β values, as presented above,
provides important clues for discriminating between βav
differences due to the methylation status and to the gen-
omic polymorphisms affecting the analyzed CpG.
A clear tri-modal distribution of individual β values
almost invariably indicates the presence of a genomic
polymorphism in the first position of CpG sites interro-
gated by type II probes. The discussed distributions,
directly reflecting the distribution of genotypes of the
polymorphic positions, can only be observed if CpG
alleles are methylated. In this context it has to be
remembered that sequences targeted by type II probes,
typically located outside of the promoter regions, are
more likely to be methylated than sequences examined
by type I probes, and thus probably more prone to the
discussed effects. A bi-modal distribution often reflects
the presence of a SNP in the second position of CpGs
interrogated by type I or type II probes, or the presence
of a SNP in the first position of CpG interrogated by
some of type I probes.
Another alerting distribution is characterized by the
increase of individual β values in samples where CpG
dinucletide is mutated to a non-CpG allele (and there-
fore is not “methylable”). In these cases it is advisable to
inspect individual values of normalized fluorescence
signals in search for cases where the sum of intensities
of both fluorescence signals (green and red) are abnor-
mally low compared to other samples. When Infinium
probes efficiently hybridize to the interrogated locus, the
increase of the green signal indicating methylation
occurs at the cost of the red signal indicating lack of
methylation, and vice-versa. In case of an inefficient
hybridization of the probes (which can be caused by thepresence of SNPs but also other confounding factors), in-
dividual beta values are artificially inflated, leading to a
high βav value estimate, which does not reflect real methy-
lation status of the analysed population/group. It is im-
portant to realize that this effect can be only appreciated
when individual fluorescence signals are examined.
Conclusions
Impact of SNPs in CpGs on comparative population studies
Some observations regarding the impact of SNPs on the
results from Illumina HM450K array have been reported
in earlier studies on methylation in tissues and pheno-
types [12, 16, 19], but this issue was never examined in
detail. In our study, which, unlike the previous ones, was
based on the inter-population comparisons, the effect of
SNPs was more conspicuous due to the high level of
SNPs heterozygosity in the examined groups. In the
analyzed set of 96 probes, preliminarily selected as
differentiating two analyzed populations (Mdiff >1), 66
(over 68 %) interrogated CpGs carrying frequent SNPs
with strongly differentiating allele frequencies. It can be
envisioned that a similar proportion (although not
necessarily the same CpGs) would be affected by SNPs
in other inter-population comparisons. Therefore, a
conscious interpretation of Illumina HM450K array is an
imperative in comparative methylation studies.
The recently published list of Infinium probes affected
by factors that confound methylation readouts in Illu-
mina HM450K array [19], is a useful reference. However,
one has to keep in mind that, in that study, the selection
of probes affected by SNPs in the interrogated CpGs has
been based on the 135 release of the Ensembl Database,
with some of the SNPs still not validated. Moreover,
some populations have a specific distribution of SNP al-
leles, and in comparative population studies on methyla-
tion, the impact of genomic SNPs will depend on the
population frequency of the polymorphism. Therefore,
while in silico analysis based on the available resources
(like the Naeem’s list of Illumina probes) should allow
rejection of the majority of common SNPs, some non-
recognized SNPs may still affect data analysis. Our study
clearly indicates that the observation of a bi-, and espe-
cially a tri-modal distribution of β values should prompt
a careful inspection of the results from Illumina Bead
Chip microarrays. In some cases, genotyping of the
analyzed samples should be recommended to check for
the presence of a still undiscovered genomic variability.
On the other hand, we do not recommend blindly
discarding all the probes from the Naeem’s list [19]. In
this context it is worth mentioning that cgx* probe
mentioned above had been marked on that list to be
“discarded”, based on the presence of a SNP in the inter-
rogated CpG. However, the SNP in question had a very
low frequency of the non-CpG allele, and in both
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site was not polymorphic at all, indicating that the ob-
served variation in β values was related to real inter-
population differences in the level of methylation.
It has been estimated that only a small fraction of
CpGs across the genome vary in their methylation
across human populations [13, 22]. In line with these
observations, our data demonstrate that all CpG sites
without any confounding effects, and thus supposedly
indicating true methylation status of the samples, repre-
sent very low inter-population differences, with Mdif in
the range of 1.1–2.9 (manuscript in preparation). Our
data suggest that the best candidates for comparative
methylation studies could be found among probes with
the “cloudy” distribution of individual β values. Some
probes with such a pattern were classified as “clean”
(free of SNP and other confounding effects); others had
SNPs in the interrogated CpGs. The observed cloudy
pattern in the latter could be due to overlapping effects,
with the methylation differences “masked” by the pres-
ence of a SNP. Discarding such probes (solely based on
the distribution of B values, with no confirmation of the
existence of SNP in the interrogated sequence) may lead
to missing some possibly important methylation differ-
ences. Inspection of individual probes in search for a
“cloudy” appearance of the β values distribution may
help to find out, which probes should be retained for the
analysis, even if a SNP is present.
Accounting for the presence of SNPs potentially con-
founding the readout of methylation signals should be
mandatory in any research involving comparison of
methylation level in populations. This may be crucial
not only in comparative population studies, but also in a
medical research during control group selection, when a
natural SNP variation existing in a population could be
incorrectly interpreted as revealing methylation state
associated with the disease.Methods
Samples processing
Human B-lymphocyte cell lines representing Caucasian
from Georgia (n = 18), further referred to as Europeans
and Han Chinese from Bejing, further referred to as East
Asians (n = 18) populations were used in the study. All
lines were derived from unrelated healthy adults males
(Europeans: 22–56 years old; mean 44 + − 9.4; Chinese:
over 18 years old). The cells were cultured under the
same standard conditions and harvested at 1 million cell
lines per 1 ml. Shortly, immortalized B lymphocytes
were purchased from Coriell Cell Repositories. Cells
were grown in RPMI medium supplemented with 10 %
FBS, 2 % glutamine and 1 % HEPES as well as 1 % peni-
cillin/streptomycin solution (all from Sigma—Aldrich,Steinheim, Germany). Cell lines were maintained in
suspension in T flasks in a humidified 5 % CO2 atmos-
phere at 37 °C.
DNA samples isolated from the cell lines were bisulfite
converted (according to Zymo Research protocol) and
analysed using Illumina Infinium HumanMethylation450
BeadChip array (HM450K, Illumina Inc). Samples were
evenly distributed between three slides: on each slide 6
European and 6 Asian samples were analysed. The quality
control was performed in Genome Studio Methylation
Module (Illumina), according to the Illumina recommen-
dations. All the samples passed the quality criteria.
Genotyping of genomic SNPs in CpG loci was based
on the 1000 Genomes database resources and/or direct
sequencing of PCR products (primers and PCR condi-
tions are available from the authors upon request).
The study was approved by the Bioethical Committee at
the Central Clinical Hospital of the Ministry of Interior in
Warsaw (No 67/2100).Data analysis
The data were preprocessed using the quantile nor-
malization method SWAN (Subset-quantile Within Array
Normalisation) [23], implemented in the minfi Bioconductor
package [24]. The widely accepted and used SWAN method
was selected because it improves the results obtained from
450 k array and leads to better detection of differential meth-
ylations, by reducing the technical variation within and
between arrays whilst maintaining the information related to
important biological features [23].
To evaluate the batch effect, we performed the
unsupervised analysis (multidimensional scaling on 1000
probes with the highest variance; done in minfi package).
The main source of variation in the dataset represented
the difference between European and East Asian popula-
tion; no batch effect related to the difference between
arrays was observed (data not shown).
To check, whether the pre-processing filtering of
probes has the significant impact on the results of our
analysis, we calculated the detection P for all the probes.
There were 2844 failed probes with a detection p-value
greater than 0.01 in at least one sample. We filtered out
all the 2844 failed probes from the normalized data and
applied the Student’s t-test followed by FDR. We applied
the criteria described in the paper (q-value < 0.05 and
abs(M_diff ) > 1) to select differentially methylated CpGs
and obtained 76 such probes (instead of 96). However,
the four probes that are described in details in the paper
passed the criteria of differentially expressed genes. It
shows that adding the filtering step does not have an
influence on the paper’s conclusions.
For each site and each individual, β values (represent-
ing the ratio of intensities between methylated and
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ing formula:
β ¼ signalMeth = signalMeth þ signalUnmeth
 
:
β values, ranging from 0 (100 % unmethylated) to 1
(100 % methylated), have a more intuitive biological
interpretation and were used here for visualization of
signals from individual measurements. M values, which
are more statistically valid for differential analysis [25, 26],
were calculated using the following formula (with a
constraint that β value is in the interval between 0.001
and 0.999):
M ¼ log2 β = 1 ‐ βð Þ½ 
¼ log2 signalMeth = signalUnmeth
 
:
To identify differentially methylated CpGs, the Student’s
t-test was performed and absolute values of Mav_diff (the
differences between average methylation levels in the two
populations) were calculated for each interrogated
position. After correction for multiple testing (false dis-
covery rate, FDR) [27, 28], only CpG sites characterized by
q < 0.05 were retained. The global methylation in each
sample was calculated as the mean beta value of all CpG
sites. Student’s t-test was performed to test whether there
is a significant difference between global methylation
levels in both populations.
Illumina probes
Illumina HM450K array consists of two assays, Infinium I
and II (see also Tables 1 and 2). Infinium I assay involves
two types of probes, U and M, complementary to
unmethylated and methylated sequence of interest, re-
spectively. The U and M probe sequences, complementary
to the interrogated CpG and to the downstream genomic
sequence, differ both at their 3′ ends (complementary to
the targeted CpG site) and at all positions complementary
to other neighboring CpG sites covered by the probe se-
quence. According to the co-methylation principle [29],
methylation status of any neighboring CpG dinucleotide is
consistent with that of the interrogated CpG site. Thus, U
probes are complementary to the unmethylated CpG sites
(converted to TpGs after bisulfite treatment of the gen-
omic DNA) along their whole sequence, whereas M
probes are complementary to the methylated CpG sites
(not affected by the bisulfite treatment). Methylation sta-
tus is assessed by comparing fluorescence signals resulting
from a single base extension (determined by the adjacent
upstream DNA sequence) of both probes (M vs U), after
their specific hybridization to, respectively, methylated or
unmethylated CpG locus. Infinium II assay involves only
one probe per interrogated CpG locus. Probe’s sequence is
complementary to the genomic sequence downstream
from the targeted CpG (the 3′-most position of a type IIprobe is complementary to the second position of the in-
terrogated CpG); the probe’s sequence is degenerated
(CpG/TpG) at each of the neighboring CpGs. Methylation
status is measured based on a single nucleotide extension
complementary to the 1st position of the interrogated
CpG, depending on the methylation status in the bisulfite-
converted DNA; differentially labeled G or A indicate
methylated or unmethylated status, respectively. For both
types of Infinium probes, the quantitative assessment of
signals generated by probes for each of the interrogated
CpGs is reported.
Throughout this text, we use the term “under-a-probe”
to describe the genomic sequence complementary to
that of the probe, but excluding the interrogated CpG.
Availability of supporting data
The data discussed in this publication have been depos-
ited in NCBI’s Gene Expression Omnibus [30] and are




The authors declare that they have no competing interests.
Authors’ contributions
PD-R - participated in the design of the study, carried out in sillico analysis
and molecular studies, and drafted manuscript. AP- performed the statistical
and bioinformatics analysis and helped to draft manuscript. JŻ-G and DR -
participated in sample preparation and performed Illumina Infinium
microarrays and statistics analysis. ASz- handled tissue cultures and
participated in sample preparation. BJ, MW and EZ- participated in the
design of the study and critically revised the manuscript. All authors have
read and approved the final manuscript.
Funding
The study was supported by the grant AriaDNA OR00 0027 12 from the
NCRD (BJ, EZ).
Author details
1Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
2Department of Nuclear Medicine and Endocrine Oncology, Maria
Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
Branch, Gliwice, Poland. 3International Institute of Molecular and Cell Biology,
Warsaw, Poland.
Received: 20 May 2015 Accepted: 11 November 2015
References
1. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, et al.
Disease-associated epigenetic changes in monozygotic twins discordant for
schizophrenia and bipolar disorder. Hum Mol Genet. 2011;20:4786–96.
2. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG,
et al. Increased methylation variation in epigenetic domains across cancer
types. Nat Genet. 2011;43:768–75.
3. Meissner A, Gnirke A, Bell GW, Ramsahoye B, Lander ES, Jaenisch R. Reduced
representation bisulfite sequencing for comparative high-resolution DNA
methylation analysis. Nucleic Acids Res. 2005;33:5868–77.
4. Zuo T, Tycko B, Liu TM, Lin JJ, Huang TH. Methods in DNA methylation
profiling. Epigenomics. 2009;1:331–45.
5. Brinkman AB, Simmer F, Ma K, Kaan A, Zhu J, Stunnenberg HG. Whole-
genome DNA methylation profiling using MethylCap-seq. Methods.
2010;52:232–6.
Daca-Roszak et al. BMC Genomics  (2015) 16:1003 Page 13 of 136. Gupta R, Nagarajan A, Wajapeyee N. Advances in genome-wide DNA
methylation analysis. Biotechniques. 2010;49:iii–xi.
7. Laird PW. Principles and challenges of genomewide DNA methylation
analysis. Nat Rev Genet. 2010;11:191–203.
8. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, et al. High density DNA
methylation array with single CpG site resolution. Genomics. 2011;98:288–95.
9. Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al.
Validation of a DNA methylation microarray for 450,000 CpG sites in the
human genome. Epigenetics. 2011;6:692–702.
10. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The
human colon cancer methylome shows similar hypo- and hypermethylation
at conserved tissue-specific CpG island shores. Nat Genet. 2009;41:178–86.
11. Kraszewska MD, Dawidowska M, Larmonie NS, Kosmalska M, Sędek Ł,
Szczepaniak M, et al. Polish Pediatric Leukemia Lymphoma Study Group:
DNA methylation pattern is altered in childhood T-cell acute lymphoblastic
leukemia patients as compared with normal thymic subsets: insights into
CpG island methylator phenotype in T-ALL. Leukemia. 2012;26:367–71.
12. Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW,
et al. Discovery of cross-reactive probes and polymorphic CpGs in the
Illumina Infinium HumanMethylation450 microarray. Epigenetics.
2013;8:203–9.
13. Heyn H, Moran S, Hernando-Herraez I, Sayols S, Gomez A, Sandoval J, et al.
DNA methylation contributes to natural human variation. Genome Res.
2013;23:1363–72.
14. Majchrzak-Celińska A, Paluszczak J, Kleszcz R, Magiera M, Barciszewska AM,
Nowak S, et al. Detection of MGMT, RASSF1A, p15INK4B, and p14ARF
promoter methylation in circulating tumor-derived DNA of central nervous
system cancer patients. J Appl Genet. 2013;54:335–44.
15. Szmida E, Karpiński P, Leszczynski P, Sedziak T, Kielan W, Ostasiewicz P, et al.
Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
J Appl Genet. 2015;56:185–92.
16. Price ME, Cotton AM, Lam LL, Farré P, Emberly E, Brown CJ, et al. Additional
annotation enhances potential for biologically-relevant analysis of the
Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics
Chromatin. 2013;6:4.
17. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F.
Evaluation of the infinium methylation 450 K technology. Epigenomics.
2011;3:771–84.
18. Dedeurwaerder S, Defrance M, Bizet M, Calonne E, Bontempi G, Fuks F.
A comprehensive overview of Infinium HumanMethylation450 data
processing. Brief Bioinform. 2014;15:929–41.
19. Naeem H, Wong NC, Chatterton Z, Hong MK, Pedersen JS, Corcoran NM,
et al. Reducing the risk of false discovery enabling identification of
biologically significant genome-wide methylation status using the
HumanMethylation450 array. BMC Genomics. 2014;15:51.
20. Touleimat N, Tost J. Complete pipeline for Infinium(®) Human Methylation
450 K BeadChip data processing using subset quantile normalization for
accurate DNA methylation estimation. Epigenomics. 2012;4:325–3241.
21. Biswas S, Scheinfeldt LB, Akey JM. Genome-wide Insights into the patterns
and determinants of fine-scale population structure in humans. Am J Hum
Genet. 2009;84:641–50.
22. Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, Laird PW, et al.
Epigenetic profiling of somatic tissues from human autopsy specimens
identifies tissue- and individual-specific DNA methylation patterns. Hum Mol
Genet. 2009;24:4808–17.
23. Maksimovic J, Gordon L, Oshlack A. SWAN. Subset-quantile within array
normalization for illumina infinium HumanMethylation450 BeadChips.
Genome Biol. 2012;13:R44.
24. Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD,
et al. Minfi: a flexible and comprehensive Bioconductor package for the
analysis of Infinium DNA methylation microarrays. Bioinformatics.
2014;30:1363–9.
25. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of
Β-value and M-value methods for quantifying methylation levels by
microarray analysis. BMC Bioinformatics. 2010;11:587.
26. Marabita F, Almgren M, Lindholm ME, Ruhrmann S, Fagerström-Billai F,
Jagodic M, et al. An evaluation of analysis pipelines for DNA methylation
profiling using the Illumina HumanMethylation450 BeadChip platform.
Epigenetics. 2013;8:333–46.
27. Storey JD. The positive false discovery rate: a Bayesian interpretation and
the q-value. Ann Stat. 2003;31:2013–35.28. Storey JD, Tibshirani R. Statistical significance for genome-wide studies.
Proc Natl Acad Sci U S A. 2003;100:9440–5.
29. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA
methylation profiling of human chromosomes 6, 20 and 22. Nat Genet.
2006;38:1378–85.
30. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene
expression and hybridization array data repository. Nucleic Acids Res.
2002;30:207–10.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
